La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

MedX Health Gestion

Gestion contrôle des critères 2/4

Le PDG MedX Health's est Stephen Lockyer, nommé en May2023, a un mandat de 1.25 ans. détient directement 0.039% des actions de la société, d'une valeur de CA$ 5.36K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.1 ans et 6.3 ans.

Informations clés

Stephen Lockyer

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	1.3yrs
Propriété du PDG	0.04%
Durée moyenne d'occupation des postes de direction	3.2yrs
Durée moyenne du mandat des membres du conseil d'administration	6.3yrs

Mises à jour récentes de la gestion

Recent updates

PDG

Stephen Lockyer

1.3yrs

Titularisation

Mr. Stephen Lockyer serves as Director of MedX Health Corp since April 12, 2023 and serves as its Chief Executive Officer since May 11, 2023. He co founded Cornwallis Financial Corporation and serves as it...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Christopher Freeman	Corporate Secretary & Acting CFO	2.4yrs	CA$14.93k	pas de données
Michael Druhan	President of Dermatological Services & Products	4yrs	CA$273.52k	pas de données
Stephen Lockyer	CEO & Director	1.3yrs	pas de données	0.039% CA$ 5.4k
Scott Naughton	Managing Director of US Operations	7.8yrs	pas de données	pas de données

3.2yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de MDX est considérée comme expérimentée (ancienneté moyenne 3.1 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Stephen Lockyer	CEO & Director	1.4yrs	pas de données	0.039% CA$ 5.4k
David Henniger	Independent Vice Chairman	22.8yrs	pas de données	1.28% CA$ 177.6k
Kenneth McKay	Independent Chairman	22.8yrs	pas de données	0.31% CA$ 43.4k
Daniel Siegel	Member of Medical Advisory Board	6.3yrs	pas de données	pas de données
Dennis Reich	Member of Medical Advisory Board	7.6yrs	pas de données	pas de données
Trevor Champagne	Chairman of Medical Advisory Board	6.1yrs	pas de données	pas de données
Joe Walls	Member of Medical Advisory Board	no data	pas de données	pas de données
Per Hall	Member of Medical Advisory Board	no data	pas de données	pas de données
Edmund Ho	Independent Director	1.4yrs	pas de données	4.41% CA$ 611.6k

6.3yrs

Durée moyenne de l'emploi

73yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de MDX sont considérés comme expérimentés (ancienneté moyenne 6.3 ans).

MedX Health Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2023)

New major risk - Market cap size

MedX Health Corp announced that it has received CAD 1.05 million in funding

First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)

Full year 2023 earnings released: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022)

MedX Health Corp announced that it expects to receive CAD 2 million in funding

New major risk - Share price stability

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 3Q 2022)

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp announced that it has received CAD 1.02 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2022)

New major risk - Share price stability

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 1Q 2022)

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.03 loss in FY 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Third quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 3Q 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.019 loss in FY 2020)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Chairman of the Board Robert von der Porten has left the company

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2020)

COO & MD of Light Therapy Products recently sold CA$53k worth of stock

First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020)

MedX Health Corp announced that it expects to receive CAD 2.5 million in funding

Full year 2020 earnings released: CA$0.019 loss per share (vs CA$0.023 loss in FY 2019)

MedX Health Corp. Announces Retirement of Board Members

EMPOWER CLINICS INC. and MedX Health Corporation Announce Memorandum of Understanding to Pilot MedX's Leading-Edge DermSecure Screening Platform At Two Select Empower Clinics Locations in Ontario

MedX Health Corp. Announces the Appointment of Paul Karam as Sales and Marketing Director for Europe, Middle East, Africa (EMEA)

New 90-day high: CA$0.24

MedX Health Corp announced that it expects to receive CAD 4 million in funding

MedX Health Corporation Appoints Trevor Champagne as Chair Medical Advisory Board

Medx Health Corp. Announces the Rollout of DermSecure in the Netherlands

Third quarter 2020 earnings released: CA$0.006 loss per share

MedX Health Corp Announces Board Changes

Medx Health Corp. Appoints Anthony Milonas and Wayne Cockburn as Directors

First half earnings released

MedX Health Corp. Announces Management Appointments

MedX Health Corp announced that it expects to receive CAD 2 million in funding

PDG

Titularisation

Équipe de direction

Durée moyenne de l'emploi

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen